CNA Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,761
Closed -$517K 143
2022
Q3
$517K Sell
2,761
-2,000
-42% -$422K 0.2% 111
2022
Q2
$773K Sell
4,761
-350
-7% -$55.4K 0.27% 76
2022
Q1
$961K Buy
5,111
+990
+24% +$188K 0.3% 80
2021
Q4
$1.09M Sell
4,121
-620
-13% -$167K 0.29% 89
2021
Q3
$1.37M Sell
4,741
-230
-5% -$59K 0.37% 61
2021
Q2
$992K Buy
4,971
+170
+4% +$33K 0.28% 115
2021
Q1
$933K Buy
4,801
+140
+3% +$28.7K 0.29% 102
2020
Q4
$893K Sell
4,661
-30
-0.6% -$5.46K 0.28% 105
2020
Q3
$692K Sell
4,691
-980
-17% -$140K 0.25% 104
2020
Q2
$701K Buy
+5,671
New +$667K 0.28% 93

Other funds holding RGEN

CNA Financial's RGEN Position: Q4 2022 in Review

CNA Financial sold out of Repligen (RGEN) in Q4 2022, closing a stake of 2,761 shares — an estimated $517K sold.

CNA Financial first reported a position in RGEN in Q2 2020 and held it in 10 quarters. The position peaked at $1.37M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • CNA Financial reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • CNA Financial sold 2,761 Repligen shares in Q4 2022, an estimated $517K.
  • CNA Financial first reported a position in Repligen in Q2 2020 and held it in 10 quarters.
  • CNA Financial's Repligen position peaked at $1.37M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on CNA Financial's 13F filing for Q4 2022, filed 10 Feb 2023.